114 related articles for article (PubMed ID: 38462023)
1. Investigating the effect of hesperetin on estrogen receptor alpha (ERα) expression, phosphorylation and activity in MCF-7 cells.
Vosooghi R; Motavalizadehkakhky A; Mansouri A; Mehrzad J; Homayouni M
Gene; 2024 Jun; 911():148357. PubMed ID: 38462023
[TBL] [Abstract][Full Text] [Related]
2. Endocrine therapy resistance can be associated with high estrogen receptor alpha (ERalpha) expression and reduced ERalpha phosphorylation in breast cancer models.
Kuske B; Naughton C; Moore K; Macleod KG; Miller WR; Clarke R; Langdon SP; Cameron DA
Endocr Relat Cancer; 2006 Dec; 13(4):1121-33. PubMed ID: 17158758
[TBL] [Abstract][Full Text] [Related]
3. The effect of hesperetin on estrogen receptor gene expression and its relationship with the downstream pathways of estrogen receptor alpha.
Bideh M; Safari S; Khedri A; Zangooei M
Mol Biol Rep; 2023 Sep; 50(9):7225-7236. PubMed ID: 37418087
[TBL] [Abstract][Full Text] [Related]
4. Liver kinase B1 expression (LKB1) is repressed by estrogen receptor alpha (ERα) in MCF-7 human breast cancer cells.
Linher-Melville K; Zantinge S; Singh G
Biochem Biophys Res Commun; 2012 Jan; 417(3):1063-8. PubMed ID: 22226967
[TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor α mediates proliferation of breast cancer MCF-7 cells via a p21/PCNA/E2F1-dependent pathway.
Liao XH; Lu DL; Wang N; Liu LY; Wang Y; Li YQ; Yan TB; Sun XG; Hu P; Zhang TC
FEBS J; 2014 Feb; 281(3):927-42. PubMed ID: 24283290
[TBL] [Abstract][Full Text] [Related]
6. The Aryl Hydrocarbon Receptor Ligand 6-Formylindolo(3,2-b)carbazole Promotes Estrogen Receptor Alpha and c-Fos Protein Degradation and Inhibits MCF-7 Cell Proliferation and Migration.
Cano-Sánchez J; Murillo-González FE; de Jesús-Aguilar J; Cabañas-Cortés MA; Tirado-Garibay AC; Elizondo G
Pharmacology; 2023; 108(2):157-165. PubMed ID: 36657432
[TBL] [Abstract][Full Text] [Related]
7. Sodium arsenite inhibited genomic estrogen signaling but induced pERα (Ser118) via MAPK pathway in breast cancer cells.
Nakareangrit W; Thiantanawat A; Visitnonthachai D; Watcharasit P; Satayavivad J
Environ Toxicol; 2016 Sep; 31(9):1133-46. PubMed ID: 25728338
[TBL] [Abstract][Full Text] [Related]
8. Estrogen receptor alpha mediates epithelial to mesenchymal transition, expression of specific matrix effectors and functional properties of breast cancer cells.
Bouris P; Skandalis SS; Piperigkou Z; Afratis N; Karamanou K; Aletras AJ; Moustakas A; Theocharis AD; Karamanos NK
Matrix Biol; 2015 Apr; 43():42-60. PubMed ID: 25728938
[TBL] [Abstract][Full Text] [Related]
9. Prenylation inhibitors stimulate both estrogen receptor alpha transcriptional activity through AF-1 and AF-2 and estrogen receptor beta transcriptional activity.
Cestac P; Sarrabayrouse G; Médale-Giamarchi C; Rochaix P; Balaguer P; Favre G; Faye JC; Doisneau-Sixou S
Breast Cancer Res; 2005; 7(1):R60-70. PubMed ID: 15642170
[TBL] [Abstract][Full Text] [Related]
10. The citrus flavonone hesperetin prevents letrozole-induced bone loss in a mouse model of breast cancer.
Li F; Chow S; Cheung WH; Chan FL; Chen S; Leung LK
J Nutr Biochem; 2013 Jun; 24(6):1112-6. PubMed ID: 23238426
[TBL] [Abstract][Full Text] [Related]
11. Naloxone acts as an antagonist of estrogen receptor activity in MCF-7 cells.
Farooqui M; Geng ZH; Stephenson EJ; Zaveri N; Yee D; Gupta K
Mol Cancer Ther; 2006 Mar; 5(3):611-20. PubMed ID: 16546975
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of PI3K/Akt signaling by 17beta-estradiol through activation of estrogen receptor-alpha, but not estrogen receptor-beta, and stimulates cell growth in breast cancer cells.
Lee YR; Park J; Yu HN; Kim JS; Youn HJ; Jung SH
Biochem Biophys Res Commun; 2005 Nov; 336(4):1221-6. PubMed ID: 16169518
[TBL] [Abstract][Full Text] [Related]
13. Requirement of ERα and basal activities of EGFR and Src kinase in Cd-induced activation of MAPK/ERK pathway in human breast cancer MCF-7 cells.
Song X; Wei Z; Shaikh ZA
Toxicol Appl Pharmacol; 2015 Aug; 287(1):26-34. PubMed ID: 26006730
[TBL] [Abstract][Full Text] [Related]
14. Reprogramming of non-genomic estrogen signaling by the stemness factor SOX2 enhances the tumor-initiating capacity of breast cancer cells.
Vazquez-Martin A; Cufí S; López-Bonet E; Corominas-Faja B; Cuyàs E; Vellon L; Iglesias JM; Leis O; Martín AG; Menendez JA
Cell Cycle; 2013 Nov; 12(22):3471-7. PubMed ID: 24107627
[TBL] [Abstract][Full Text] [Related]
15. Furanodienone inhibits cell proliferation and survival by suppressing ERα signaling in human breast cancer MCF-7 cells.
Li YW; Zhu GY; Shen XL; Chu JH; Yu ZL; Fong WF
J Cell Biochem; 2011 Jan; 112(1):217-24. PubMed ID: 21069738
[TBL] [Abstract][Full Text] [Related]
16. Triptolide inhibits human breast cancer MCF-7 cell growth via downregulation of the ERα-mediated signaling pathway.
Li H; Pan GF; Jiang ZZ; Yang J; Sun LX; Zhang LY
Acta Pharmacol Sin; 2015 May; 36(5):606-13. PubMed ID: 25864647
[TBL] [Abstract][Full Text] [Related]
17. Antagonist-induced, activation function-2-independent estrogen receptor alpha phosphorylation.
Lipfert L; Fisher JE; Wei N; Scafonas A; Su Q; Yudkovitz J; Chen F; Warrier S; Birzin ET; Kim S; Chen HY; Tan Q; Schmidt A; Dininno F; Rohrer SP; Hammond ML; Rodan GA; Freedman LP; Reszka AA
Mol Endocrinol; 2006 Mar; 20(3):516-33. PubMed ID: 16223974
[TBL] [Abstract][Full Text] [Related]
18. Leptin attenuates the anti-estrogen effect of tamoxifen in breast cancer.
Chen X; Zha X; Chen W; Zhu T; Qiu J; Røe OD; Li J; Wang Z; Yin Y
Biomed Pharmacother; 2013 Feb; 67(1):22-30. PubMed ID: 23199901
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of LRP16 mRNA by 17beta-estradiol through activation of estrogen receptor alpha (ERalpha), but not ERbeta, and promotion of human breast cancer MCF-7 cell proliferation: a preliminary report.
Han WD; Mu YM; Lu XC; Xu ZM; Li XJ; Yu L; Song HJ; Li M; Lu JM; Zhao YL; Pan CY
Endocr Relat Cancer; 2003 Jun; 10(2):217-24. PubMed ID: 12790785
[TBL] [Abstract][Full Text] [Related]
20. The individual or combinational effects of Hesperetin and Letrozole on the activity and expression of aromatase in MCF-7 cells.
Rahideh ST; Shidfar F; Nourbakhsh M; Hoseini M; Koohdani F; Entezam M; Keramatipour M
Cell Mol Biol (Noisy-le-grand); 2016 May; 62(6):38-43. PubMed ID: 27262800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
